Reimagining Drug Discovery Process with AI - Isomorphic Labs
Our Team
Our Tech
Partnerships
Careers
Life At Iso
Work With Us
Job Openings
News
Our Team
Our Tech
Partnerships
Careers
Life at Iso
Work with Us
Job Openings
News
Solve
all disease
We’re entering a new era of drug discovery — one where frontier AI can unlock deeper scientific insights, faster breakthroughs, and life-changing medicines. At Isomorphic Labs, we’re building that future.
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system.
Our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed.
Every day, and with each new breakthrough, we’re getting closer to the promise of digital biology, and achieving our ambitious mission to one day solve all disease with the help of AI.
Latest from ISO
View All
Our approach to bioresilience
Isomorphic Labs announces Series B investment round
The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold
our goalWe’re using machine learning to transform drug discovery.
work with us
OUR LEADERSHIP
Meet the Isos powering our progress.
Our Team
OUR CULTURE
Advance your career at a company that’s shaping the future.
Life at Iso
OUR HERITAGE
AlphaFold broke new ground. Iso has built on it.
Our Tech
Isomorphism
Our name comes from the belief that there is an underlying symmetry in the universe - between biology and information science. By harnessing AI’s powerful capabilities, we can use it to model complex biological phenomena in order to help design novel molecules, anticipate how drugs will perform, and develop innovative medicines to treat and cure some of the world’s most devastating diseases.
Our Tech
“I believe there is no more important application for AI than helping to improve human health.”
“I believe there is no more important application for AI than helping to improve human health.”
SIR DEMIS HASSABIS
FOUNDER AND CEO
Latest from Iso
Announcement
Our approach to bioresilience
18.02.25
Announcement
Isomorphic Labs announces Series B investment round
18.02.25
Vision
The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold
18.02.25
More News
© 2026 ISOMORPHIC LABS
Home
Life at Iso
Our Team
Work With Us
Our Tech
Job Openings
Partnerships
News
Linkedin
X
CONTACT US
press@isomorphiclabs.com
partnering@isomorphiclabs.com
connecting@isomorphiclabs.com
INFO
Privacy Notice
Cookie Notice
Terms & Conditions
Supplier Code of Conduct
Manage Cookies
Show Browser Info